David Nutt and Global Experts Gather for Europe’s Premier Psychedelic Science Conference
Europe’s leading psychedelic medicine conference, PSYCH Symposium, will return to London on December 4, 2025, bringing together scientists, clinicians, investors and policymakers to explore the future of psychedelic-assisted therapies. The event will take place at Conway Hall, co-organized by Prohibition Partners and Drug Science, with Psychedelic Health as a media partner. Tickets and information are […]
Set, Setting, and Solidarity: Inside The Launch of Global Psychedelic Week
The psychedelic renaissance is in full bloom, reshaping not only scientific and medical communities but also mainstream culture. After decades of prohibition and stigma, substances like psilocybin, LSD, MDMA, and ayahuasca are being reexamined through rigorous clinical research, showing promise in treating depression, PTSD, addiction, and end-of-life anxiety. From Johns Hopkins to MAPS, leading institutions […]
Former GOP House Speaker Promotes ‘Cutting-Edge’ Science Of The Psychedelic Ibogaine
Former U.S. House Speaker Newt Gingrich (R-GA) is again highlighting the potential benefits of the powerful psychedelic ibogaine for people with serious mental and physical health conditions. In an episode of his podcast Newt’s World, the former speaker spoke with the co-founders of Ambio Life Sciences, a company providing ibogaine treatment in Mexico. Gingrich said […]